News
Regeneron Factor XI Antibodies Show Strong Antithrombotic Effects
Pune, India | November 10, 2025 Regeneron Pharmaceuticals recently announced encouraging Phase 2 trial outcomes for two investigational Factor XI antibodies, highlighting progress in clot-prevention therapies. The
Read More